ch.oddb.org
 
Medikamente | Services | Zulassungsi.
Fachinformation zu Peyona® Infusionslösung und Lösung zum Einnehmen:Chiesi SA
Vollst. FachinformationDDDÄnderungen anzeigenDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info. 
N06BC01 - CaffeineATC-DDD Version 2016. Source: WHO
N - Nervous System
 
N06 - Psychoanaleptics

This group comprises antidepressants, psychostimulants, nootropics, anti-dementia drugs and combinations with psycholeptics.
Antiobesity preparations are classified in A08 - Antiobesity preparations, excl. diet products.

N06B - Psychostimulants, Agents Used for Adhd and Nootropics

Some drugs used in the treatment of narcolepsy are classified here.
Nootropics are classified in N06BX.
Clonidine and guanfacine also used in ADHD are classified in C02AC.

N06BC - Xanthine Derivatives

Caffeine in combination with respiratory stimulants is classified in R07AB.

N06BC01 - Caffeine
StärkeAdm.RouteNote
 P 
 O 
2025 ©ywesee GmbH
Hilfe | FAQ | Anmeldung | Kontakt | Home